Skip to main content

About Us

We created the Carlos Simon Foundation for Research in Women’s Health in June 2022 together with a group of philanthropists, researchers, and professionals committed to advancing reproductive medicine. We are a patient- and science-centered organization with the mission of improving women’s health through three core pillars:

  • Basic research. Understanding the cellular, molecular, microbiological, and genetic complexity of the human uterus in health and disease.
  • Translation. Promoting the creation of biotechnology companies that provide clinical solutions for conditions related to female reproductive health.
  • Education. Transmitting knowledge and scientific culture to the next generations.
  • Clinical Relevance in Women’s Health Research

    • Infertility is estimated to affect 48 million couples and 186 million individuals worldwide [1]. About 35% of cases are linked to uterine dysfunction.
    • Pregnancy complications remain a major cause of morbidity and mortality: preterm birth affects 10% of pregnancies and preeclampsia 5%, resulting in 3.6 million neonatal deaths and 1 million maternal deaths globally each year [2].
    • Menopause is a universal stage for all women, with significant clinical and metabolic implications.
    • Uterine tumors are present in 70% of women worldwide [3].
    • Ovarian cancer is the deadliest gynecological cancer and the fifth leading cause of cancer death in women. [4].

    President

    Dr. Carlos Simon is a reproductive endocrinologist and physician-scientist with a distinguished international career in reproductive biology, particularly human embryo implantation.

    His research has focused on molecular communication between the maternal endometrium and the embryo, as well as the role of endometrial stem cells in uterine regeneration.

    He has published more than 550 peer-reviewed scientific articles, with over 57,000 citations and an h-index of 136 (Google Scholar, 2025). He has edited 21 books and supervised 42 doctoral theses. His contributions have been recognized with awards such as the King Jaime I Award (2011), the ASRM Distinguished Research Award (2016), the Lilly Foundation Biomedical Research Award (2021), the Translational Research Award from the Spanish Royal Academy of Medicine (2023), and the University–Society Award from the University of Valencia (2025).

    Carlos Simon Excellence in Translational Research Award

    The Carlos Simon Foundation and the American Society for Reproductive Medicine (ASRM) are pleased to announce the creation of this new award. The prize includes a monetary grant, registration to the ASRM Congress, travel support, and the opportunity to present the awarded work during the official Congress symposium.

    Learn more
    ASRM logo in white
    Carlos Simon Foundation logo in white

    Standing for Diversity

    Diversity is part of the DNA of the Carlos Simon Foundation. We promote an inclusive environment where everyone feels valued and respected, regardless of origin, identity, beliefs, or orientation. We believe that diverse perspectives enrich research, strengthen our teams, and enhance our impact on society.